Jon Christian Bates - 12 Mar 2024 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Role
Chief Financial Officer
Signature
Jon Bates
Issuer symbol
NUTX
Transactions as of
12 Mar 2024
Net transactions value
$0
Form type
4
Filing time
14 Mar 2024, 16:44:39 UTC
Previous filing
20 Jun 2023
Next filing
28 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUTX Common Stock Options Exercise +49,505 +55% 139,010 12 Mar 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUTX Restricted Stock Units Options Exercise $0 -49,505 -50% $0.000000 49,505 12 Mar 2024 Common Stock 49,505 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the settlement of restricted stock units (RSUs) that vested on March 1, 2024 through the issuance of shares of Common Stock.
F2 Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
F3 Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated April 1, 2023, the 148,515 RSUs granted to Mr. Bates will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025